Successful Induction of Immune Tolerance to Canine Factor VIII after Lentiviral-Mediated Gene Therapy in Neonatal Hemophilia A Mice

被引：0

作者：

Matsui, Hideto ^{[1
]}

Shibata, Masaru ^{[1
,2
]}

Brown, Brian ^{[1
]}

Labelle, Andrea ^{[1
]}

Hegadorn, Carol ^{[1
]}

Andrews, Chandler ^{[1
]}

Chuah, Marinee ^{[3
]}

VandenDriessche, Thierry ^{[3
]}

Miao, Carol H. ^{[4
]}

Hough, Christine ^{[1
]}

Lillicrap, David ^{[1
]}

机构：

[1] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada

[2] Nara Med Univ, Dept Pediat, Kashihara, Nara, Japan

[3] Univ Louvain, Flanders Interuniv Inst Biotechnol, Ctr Transgene Technol & Gene Therapy, Louvain, Belgium

[4] Univ Washington, Dept Pediat, Seattle, WA 98195 USA

来源：

MOLECULAR THERAPY | 2006年 / 13卷

关键词：

D O I：

10.1016/j.ymthe.2006.08.1193

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

1091

引用

页码：S419 / S419

页数：1

共 50 条

[41] OBSERVATIONAL IMMUNE TOLERANCE INDUCTION STUDY (OBSITI): IMMUNE TOLERANCE INDUCTION WITH A SINGLE FACTOR VIII/VON WILLEBRAND FACTOR CONCENTRATE FOR TREATMENT OF HEMOPHILIA A PATIENTS WITH INHIBITORS
Escuriola-Ettinghausen, C.
HAEMATOLOGICA, 2019, 104 : 13 - 14
[42] Longitudinal profiling of anti-factor VIII antibodies in Japanese patients with congenital hemophilia A during factor VIII replacement and immune-tolerance induction therapy
Takuji Yoshimura
Shoko Furukawa
Akihisa Oda
Tomoko Matsumoto
Kana Sasai
Midori Shima
Keiji Nogami
International Journal of Hematology, 2022, 116 : 423 - 433
[43] Longitudinal profiling of anti-factor VIII antibodies in Japanese patients with congenital hemophilia A during factor VIII replacement and immune-tolerance induction therapy
Yoshimura, Takuji
Furukawa, Shoko
Oda, Akihisa
Matsumoto, Tomoko
Sasai, Kana
Shima, Midori
Nogami, Keiji
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (03) : 423 - 433
[44] Successful induction of immune tolerance to enzyme replacement therapy in canine mucopolysaccharidosis I
Kakkis, E
Lester, T
Yang, R
Tanaka, C
Anand, V
Lemontt, J
Peinovich, M
Passage, M
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (03) : 829 - 834
[45] Pharmacokinetic analysis identifies a factor VIII immunogenicity threshold after AAV gene therapy in hemophilia A mice
Lundgren, Taran S.
Denning, Gabriela
Stowell, Sean R.
Spencer, H. Trent
Doering, Christopher B.
BLOOD ADVANCES, 2022, 6 (08) : 2628 - 2645
[46] Successful use of very high purity factor VIII concentrates in an immune tolerance induction regimen in hemophilia A subjects with high responding inhibitors
Rocino, A
Papa, ML
Salerno, E
de Biasi, R
THROMBOSIS RESEARCH, 1998, 91 (03) : S96 - S96
[47] Effect of B-Cell Depletion On Inhibitor Antibody Formation and Immune Tolerance Induction to Human Factor VIII in Hemophilia A Mice
Zhang, Ai-Hong Allan
Skupsky, Jonathan
Scott, David W.
BLOOD, 2009, 114 (22) : 841 - 841
[48] Anti-CD3 antibodies modulate anti-factor VIII immune responses in hemophilia Amice after factor VIII plasmid-mediated gene therapy
Peng, Baowei
Ye, Peiqing
Rawlings, David J.
Ochs, Hans D.
Miao, Carol H.
BLOOD, 2009, 114 (20) : 4373 - 4382
[49] Novel Strategies To Modulate Pre-Existing Anti-Factor VIII Immune Responses in Hemophilia A Inhibitor Mice Treated with Factor VIII Plasmid-Mediated Gene Therapy
Liu, ChaoLien
Ye, Peiqing
Lin, Jacqueline
Miao, Carol H.
MOLECULAR THERAPY, 2012, 20 : S275 - S276
[50] Immune Tolerance Induction in Severe Hemophilia a Patients Using Wilate, a Von Willebrand Factor/Factor VIII Concentrate
Wu, John K.
Woo, Celina
Crilly, Erica
BLOOD, 2014, 124 (21)

← 1 2 3 4 5 →